此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients

2026年11月9日 更新者:Gulay ERDOGAN KAYHAN、Eskisehir Osmangazi University

Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.

研究概览

详细说明

Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.

The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.

Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.

However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.

研究类型

介入性

注册 (估计的)

70

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Gulay Erdogan Kayhan, Prof. Dr.
  • 电话号码:905332560011
  • 邮箱:drgulayer@yahoo.com

研究联系人备份

  • 姓名:Muhammed Alpaslan Uludag, Research Assistant, MD
  • 邮箱:muho.78@live.com

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

25年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients over 25 years of age
  • American Soc,ety of Anesthesiology (ASA) status I-III
  • Scheduled to undergo laparoscopic abdominal surgery
  • With an expected pneumoperitoneum duration of ≥1 hour

Exclusion Criteria:

  • Patients with ocular disease
  • Patients who have undergone cranial or ocular surgery
  • Patients with a history of laparotomy
  • Individuals with bullous lung disease
  • Patients with uncontrolled chronic obstructive lung disease
  • Patients with hemodynamic instability or decompensated heart failure
  • Patients who require conversion to an open surgical procedure for any reason

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
其他:Group O

Obese patients with BMI ≥ 30 kg/m²

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

其他:Group N

Non-obese patients

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Optic nerve sheath diameter (ONSD)
大体时间:Perioperative/Periprocedural (t0-after anesthesia induction and entubation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
Optic nerve sheath diameter (ONSD)
大体时间:Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
Optic nerve sheath diameter (ONSD)
大体时间:Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
Optic nerve sheath diameter (ONSD)
大体时间:Perioperative/Periprocedural (t3 - after desufflation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t3 - after desufflation)
Optic nerve sheath diameter (ONSD)
大体时间:Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
Optic nerve sheath diameter (ONSD)
大体时间:Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

次要结果测量

结果测量
措施说明
大体时间
MAP
大体时间:Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)

Noninvasive mean arterial pressure (mmHg)

Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
HR
大体时间:Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)

Heart rate (beat/min)

Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
etCO2
大体时间:Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

End-tidal carbon dioxide levels (mmHg)

Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

其他结果措施

结果测量
措施说明
大体时间
Airway pressures during mechanical ventilation
大体时间:Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)

Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen

Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
Postoperative complications
大体时间:PONV will be questioned at the 24th hours

Postoperative nause and vomiting (PONV)

PONV will be questioned at the 24th hours
Postoperative complications
大体时间:Headache will be questioned at the 24th hours

Headache

Headache will be questioned at the 24th hours
Postoperative complications
大体时间:Visual disturbance will be questioned at the 24th hours

Visual disturbance

Visual disturbance will be questioned at the 24th hours

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年12月1日

初级完成 (估计的)

2027年11月1日

研究完成 (估计的)

2027年11月1日

研究注册日期

首次提交

2026年11月3日

首先提交符合 QC 标准的

2026年11月9日

首次发布 (实际的)

2026年11月16日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月9日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅